Učitavanje...
First‐line treatment of advanced epidermal growth factor receptor (EGFR) mutation positive non‐squamous non‐small cell lung cancer
BACKGROUND: Epidermal growth factor receptor (EGFR) mutation positive (M+) non‐small cell lung cancer (NSCLC) is an important subtype of lung cancer comprising 10% to 15% of non‐squamous tumours. This subtype is more common in women than men, is less associated with smoking, but occurs at a younger...
Spremljeno u:
| Izdano u: | Cochrane Database Syst Rev |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
John Wiley & Sons, Ltd
2021
|
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8092455/ https://ncbi.nlm.nih.gov/pubmed/33734432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010383.pub3 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|